Tag: cell therapy manufacturing market
Cell Therapy Manufacturing Market Size, Status, Growth | Industry Analysis Report 2022-2028
The new Cell Therapy Manufacturing Market report offers a comprehensive study of the current scenario of the market including major market dynamics. Also, it highlights the in-depth marketing research with the newest trends, drivers, and segments with ref...
Growing at an annualized rate of over 16.5%, the cell therapy manufacturing market is estimated to reach close to USD 11 Billion by 2030, claims Roots Analysis
The approval of KYMIRAH®, YESCARTA®, Alofisel® and Zyntelgo® has increased the interest of pharma stakeholders in cell therapies.
The “Cell Therapy Manufacturing Market (3rd Edition), 2019-2030
The approval of KYMIRAH®, YESCARTA®, Alofisel® and Zyntelgo® has increased the interest of pharma stakeholders in cell therapies.
More than 100 industry players and over 60 non-industry players currently claim to manufacture different types of cell therapies, either for in-house requirements or on contract basis
Owing to various reasons, the demand for cell therapies is anticipated to increase over the coming years. Therefore, both therapy developers and contract service providers .
The cell therapy manufacturing market is projected to grow at an annualized rate of >16.5%, till 2030
Roots Analysis has done a detailed study on Cell Therapy Manufacturing Market (3rd Edition), 2019 - 2030, covering various important aspects of the industry and identifying key future growth opportunities.
The cell therapy manufacturing market is estimated to reach close to USD 11 Billion by 2030, predicts Roots Analysis
Manufacturing cell therapies is technically and financially demanding; as a result, despite therapy developers gradually strengthening their in-house expertise.
